| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief R&D Officer | See Remarks +1 more
1 company
Valamehr Bahram is a President And CEO at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 37 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sale+OE | 25,000 | $47.66 | $1,191,405.50 | -2.9% | -39.4% | -66.6% | |
| Sep 13, 2021 | FATE Fate Therapeutics Inc | Chief Development Officer | Sale+OE | 25,000 | $66.29 | $1,657,257.42 | -7.8% | -25.5% | -61.1% | |
| Jun 14, 2021 | FATE Fate Therapeutics Inc | Chief Development Officer | Sale+OE | 25,000 | $89.32 | $2,233,045.21 | -7.8% | -26.9% | -79.3% | |
| Mar 15, 2021 | FATE Fate Therapeutics Inc | Chief Development Officer | Sale+OE | 25,000 | $92.35 | $2,308,772.18 | -4.6% | -3.0% | -66.2% | |
| Jan 11, 2021 | FATE Fate Therapeutics Inc | Chief Development Officer | Sell | 9,484 | $114.95 | $1,090,139.84 | -1.7% | - | - | |
| Dec 14, 2020 | FATE Fate Therapeutics Inc | Chief Development Officer | Sale+OE | 25,000 | $97.78 | $2,444,476.81 | -3.2% | - | - | |
| Sep 14, 2020 | FATE Fate Therapeutics Inc | Chief Development Officer | Sale+OE | 25,000 | $36.28 | $907,024.39 | -6.2% | - | - | |
| Jan 8, 2020 | FATE Fate Therapeutics Inc | Chief Development Officer | Sell | 5,700 | $20.69 | $117,947.25 | -6.2% | - | - | |
| Oct 15, 2019 | FATE Fate Therapeutics Inc | Chief Development Officer | Sell | 6,200 | $14.18 | $87,890.58 | -8.5% | - | - |